Literature DB >> 29661730

Distribution of lymphoid neoplasms in Northwest China: Analysis of 3244 cases according to WHO classification in a single institution.

Chun Cao1, Juan Feng1, Hongtao Gu1, Hailong Tang1, Li Xu1, Hongjuan Dong1, Baoxia Dong1, Mimi Shu1, Qingxian Bai1, Rong Liang1, Tao Zhang1, Lan Yang1, Zhe Wang2, Xiequn Chen3, Guangxun Gao4.   

Abstract

To explore the distribution of lymphoid neoplasms in Northwest China, the clinical and pathological data of lymphoma patients from 2006 to 2014 were analyzed according to the WHO classification in Xijing Hospital. Of the 3244 cases, mature B-cell neoplasms occupied 60.7%, while mature T/NK-cell neoplasms and Hodgkin's lymphomas (HL) occupied 26.2% and 8.1%, respectively. The most common subtype of lymphoma was diffuse large B-cell lymphoma (35.0%), followed by extranodal NK/T-cell lymphoma, nasal type (ENKTCL) (12.9%) and marginal zone B-cell lymphoma (7.8%). Mixed cellularity (34.0%) was the most common subtype of HL. The especially high proportion of ENKTCL was the most outstanding feature of our study in comparison to previous reports. The mean age of all lymphoid neoplasms cases was 51years and most subtypes showed male predominance, with an average male-female ratio of 1.6. Extranodal lymphomas took up about 60% of all cases and gastrointestinal tract was the most frequently involved site. In conclusion, the distribution of lymphoid neoplasms of Northwest China showed some features similar to previous reports of China and other countries, but some subtypes presented distinct features.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Distribution; Lymphoid neoplasms; Northwest China; WHO classification

Mesh:

Year:  2017        PMID: 29661730     DOI: 10.1016/j.anndiagpath.2017.05.005

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  6 in total

1.  Nomograms based on SUVmax of 18F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.

Authors:  Hongyan Li; Guozhu Shao; Yajing Zhang; Xiaomin Chen; Chengcheng Du; Kun Wang; Zairong Gao
Journal:  Cancer Imaging       Date:  2021-01-08       Impact factor: 3.909

Review 2.  Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.

Authors:  Ping Zhang; Mingzhi Zhang
Journal:  Clin Epigenetics       Date:  2020-11-07       Impact factor: 6.551

Review 3.  Estimating the global burden of Epstein-Barr virus-related cancers.

Authors:  Yide Wong; Michael T Meehan; Scott R Burrows; Denise L Doolan; John J Miles
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-27       Impact factor: 4.553

4.  Subtype distribution of lymphomas in northwestern Iran: a retrospective analysis of 659 cases according to World Health Organization classification.

Authors:  Javad Jalili; Amir Vahedi; Amin Danandehmehr; Parya Aynechi; Ali Esfahani; Yousef Roosta; Hooman Nateghian; Amirhosein Ghafouri Asbagh; Fateme Hajihoseinlou
Journal:  BMC Cancer       Date:  2022-10-12       Impact factor: 4.638

5.  Algorithmic Approach to Fibroinflammatory Sinonasal Tract Lesions.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2021-03-15

6.  Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma.

Authors:  Jun Ma; Xiaojun Huang; Shenmiao Yang; Dong Dong; Hongfei Gu; Robert Peter Gale
Journal:  J Cancer Res Clin Oncol       Date:  2020-10-19       Impact factor: 4.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.